All posts tagged
More News! Cevec moves into Zika, Ablynx’s Latest MAA, EMA in CPH?
Llama-inspired Nanobody Therapy for Psoriasis clears Phase I
Smells like a Great Biotech Career: Find your Dream Job at Novoptim!
An Antibody to reduce Hospitalizations of Children starts Phase IIb trials
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie
Nanobody Phase II Results for Arthritis: Good but not good enough?
Llama Antibody Inhalation gets Positive Results for Respiratory Virus
Our Top 5 Articles on Biotech & Rare Disease
World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies
When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease
Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck
Labiotech UG, All Rights Reserved -
Send this to friend